10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-028760`
Period End Date	20190630
Filing Date	20190805
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	arwr-20190630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 65 Cash Flow Statement 56 Stockholders Equity 33

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$188.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$30.13M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.51M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	95.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.51M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$1.00M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	95.21M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$327.38K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.04M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.27M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.10M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$640.12K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.49M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$48.57M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$46.40M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$244.54M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$78.77M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$17.07M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$17.49M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$18.76M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$57.56M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.92K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$170.92K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$336.83M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$111.61M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.63M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.81M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.04M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.17M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.43M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$173.95K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$307.33K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$600.00	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$75.68M	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$223.82K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$87.09M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$12.36M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.81M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.70M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$22.26M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$2.10M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.00M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$24.07M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 95,207,637 and 88,505,302 shares issued and outstanding as of June 30, 2019 and September 30, 2018, respectively	`CommonStockValue`	$180.88K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 95,207,637 and 88,505,302 shares issued and outstanding as of June 30, 2019 and September 30, 2018, respectively	`CommonStockValue`	$187.58K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$582.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$657.14M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-103.08K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-21.56K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-431.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-487.27M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$226.23M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$95.80M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$225.67M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$101.76M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$111.61M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$336.83M	USD	Point-in-time

Income Statement 65 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.89M	USD	3 Qtrs
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$727.38K	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$42.70M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$125.50M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$19.29M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$12.05M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$36.97M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$57.66M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.81M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.59M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$16.29M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$12.68M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$24.10M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$49.65M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$73.95M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$16.65M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-15.92M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-44.77M	USD	3 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$51.55M	USD	3 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$18.60M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$645.78K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$4.72M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$313.70K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$1.74M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$432.14K	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$313.70K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$4.72M	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.74M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.08M	USD	3 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$20.34M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-15.61M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$56.27M	USD	3 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-43.69M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-15.61M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$56.27M	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$20.34M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-43.69M	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.21	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.60	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.53	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.21	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.58	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.53	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.18	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.36M	shares	3 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	82.15M	shares	3 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.94M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	87.63M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.88M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	82.15M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.81M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.63M	shares	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-31.17K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-81.51K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.60K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-36.57K	USD	3 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$56.19M	USD	3 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$20.30M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-43.73M	USD	3 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-15.63M	USD	1 Quarter

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$56.27M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-43.69M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-15.61M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$20.34M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$432.14K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$7.28M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$5.82M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.36M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.47M	USD	3 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-582.37K	USD	3 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-682.24K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-52.82K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.72M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.39M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-856.25K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$97.94M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-4.33M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.82M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.91M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-3.48M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-4.65M	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-538.02K	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-312.00K	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-44.54M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$159.23M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.17M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$711.78K	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$47.17M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$90.27M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$37.20M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$29.86M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-10.68M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-64.58M	USD	3 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$154.99K	USD	3 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$2.42M	USD	3 Qtrs
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$54.67K	USD	3 Qtrs
Proceeds from the exercises of warrants and stock options	`ProceedsFromExercisesOfWarrantsAndStockOptions`	$6.44M	USD	3 Qtrs
Proceeds from the exercises of warrants and stock options	`ProceedsFromExercisesOfWarrantsAndStockOptions`	$2.01M	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$56.59M	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$60.52M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$64.55M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$58.38M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.16M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$159.20M	USD	3 Qtrs
CASH AND RESTRICTED CASH AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$189.33M	USD	Point-in-time
CASH AND RESTRICTED CASH AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.84M	USD	Point-in-time
CASH AND RESTRICTED CASH AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.00M	USD	Point-in-time
CASH AND RESTRICTED CASH AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$30.13M	USD	Point-in-time
CASH AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$189.33M	USD	Point-in-time
CASH AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$24.84M	USD	Point-in-time
CASH AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.00M	USD	Point-in-time
CASH AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$30.13M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$27.44K	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$131.43K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$2.40K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$2.40K	USD	3 Qtrs

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$225.67M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$101.76M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.96M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.27M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.28M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.82M	USD	3 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.77M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$838.93K	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.03M	USD	3 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.44M	USD	3 Qtrs
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1.24M	shares	3 Qtrs
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$571.20K	USD	1 Quarter
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$1.24M	USD	3 Qtrs
Common stock- Restricted Stock Units vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-54.67K	USD	3 Qtrs
Common stock issued	`StockIssuedDuringPeriodValueNewIssues`	$60.52M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-31.17K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-81.51K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.60K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-36.57K	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$56.27M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-43.69M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-15.61M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$20.34M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$225.67M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$101.76M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.